These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6306084)

  • 21. Radioimmunoassay for antibodies in varicella-zoster virus serology.
    Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.
    Schmidt NJ; Lennette EH; Magoffin RL
    J Gen Virol; 1969 Apr; 4(3):321-8. PubMed ID: 4306713
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster.
    Okuno Y; Takao Y; Miyazaki Y; Ohnishi F; Okeda M; Yano S; Kumihashi H; Gomi Y; Maeda K; Ishikawa T; Mori Y; Asada H; Iso H; Yamanishi K;
    Epidemiol Infect; 2013 Apr; 141(4):706-13. PubMed ID: 23218021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
    Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic relationship between varicella-herpes zoster and herpes simplex viruses studied by the gel precipitation reaction.
    Trlifajová J; Sourek J; Ryba M
    Acta Virol; 1971 Jul; 15(4):293-300. PubMed ID: 4398080
    [No Abstract]   [Full Text] [Related]  

  • 26. Varicella-zoster virus-specific immunity after herpes zoster.
    Hayward A; Levin M; Wolf W; Angelova G; Gilden D
    J Infect Dis; 1991 Apr; 163(4):873-5. PubMed ID: 1849165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralization tests with varicella-zoster virus.
    Caunt AE; Shaw DG
    J Hyg (Lond); 1969 Jun; 67(2):343-52. PubMed ID: 4183291
    [No Abstract]   [Full Text] [Related]  

  • 28. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged.
    Berger R; Florent G; Just M
    Infect Immun; 1981 Apr; 32(1):24-7. PubMed ID: 6163722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic relationship between human cytomegalovirus, herpes simplex, and varicella-zoster virus studied by complement-fixation.
    Krech U; Jung M
    Arch Gesamte Virusforsch; 1971; 33(3):288-95. PubMed ID: 4329637
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen.
    Takahashi M; Iketani T; Sasada K; Hara J; Kamiya H; Asano Y; Baba K; Shiraki K
    J Infect Dis; 1992 Aug; 166 Suppl 1():S58-62. PubMed ID: 1320651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired specific cellular immunity to the varicella-zoster virus in patients with herpes zoster oticus.
    Ikeda M; Hiroshige K; Abiko Y; Onoda K
    J Laryngol Otol; 1996 Oct; 110(10):918-21. PubMed ID: 8977852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular immunity to varicella-zoster virus in patients with major depression.
    Irwin M; Costlow C; Williams H; Artin KH; Chan CY; Stinson DL; Levin MJ; Hayward AR; Oxman MN
    J Infect Dis; 1998 Nov; 178 Suppl 1():S104-8. PubMed ID: 9852986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro.
    WELLER TH; WITTON HM
    J Exp Med; 1958 Dec; 108(6):869-90. PubMed ID: 13598817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An immunological study of herpes zoster patients III--specific immunity (author's transl)].
    Vacek Z; Trlifajová J; Doutlík S; Vasícková M; Ryba M
    Cesk Dermatol; 1981 Feb; 56(1):11-6. PubMed ID: 6260390
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological response of patients with herpes zoster (author's transl)].
    Higa K
    Fukuoka Igaku Zasshi; 1982 Mar; 73(3):131-45. PubMed ID: 6286440
    [No Abstract]   [Full Text] [Related]  

  • 37. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
    J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous rise in complement-fixing antibodies against herpesvirus hominis and varicella-zostervirus in patients with chickenpox and shingles.
    Schaap GJ; Huisman J
    Arch Gesamte Virusforsch; 1968; 25(1):52-7. PubMed ID: 4306835
    [No Abstract]   [Full Text] [Related]  

  • 39. Varicella-zoster virus infection in pregnancy.
    Enders G
    Prog Med Virol; 1984; 29():166-96. PubMed ID: 6322232
    [No Abstract]   [Full Text] [Related]  

  • 40. Varicella virus isolation from spinal ganglion.
    Shibuta H; Ishikawa T; Hondo R; Aoyama Y; Kurata K; Matumoto M
    Arch Gesamte Virusforsch; 1974; 45(4):382-5. PubMed ID: 4374161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.